Featured News
464Wire StoriesWemade Applies Extensive Skill Balance Update for MIR4
Combat skill adjustments for all classes – Warrior, Lancer, Sorcerer, Taoist, Arbalist, Darkist Magic Square and Secret Peak expanded to 10th floor,...
- 361Wire Stories
NTT Announces Research Applying Genetic Data to Improve Athletic Performance and Health
To provide athletes tools for training, practice and game analysis based on NTT’s IoT, AI and ICT technologies TOKYO–(BUSINESS WIRE)–NTT Corporation (NTT),...
- 532Wire Stories
Hurricane Electric Expands Global Network in The Philippines With New Point of Presence at ePLDT VITRO Makati 1 in Manila
Latest Point of Presence in the Philippines brings high-speed connectivity to this rapidly growing digital economy MANILA, Philippines–(BUSINESS WIRE)–Hurricane Electric, the world’s...
- 438News
Alibaba Pictures announces to acquire Damai and transition into the flagship offline entertainment platform of the Alibaba Digital Media and Entertainment Group
HONG KONG SAR – Media OutReach – 19 September 2023 – Alibaba Pictures Group Limited (“Alibaba Pictures” or the “Company,” HKEX: 1060),...
- 535Wire Stories
FANUC Announces Production of its One Millionth Robot
Landmark achievement strengthens FANUC’s position as a global automation leader. ROCHESTER HILLS, Mich.–(BUSINESS WIRE)–#EV–FANUC CORPORATION, a global leader in Factory Automation, robotics,...
- 554Wire Stories
K-Wonderland Connects with Korean Artists Gen Z Loves
Metaverse fan party with universal entertainers Lee Eun-ji, THE BOYZ, and Just Jerk K-Wonderland, a mega Korean culture event that transcends the...
- 419Wire Stories
BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®
European Commission approves TEVIMBRA for previously treated advanced or metastatic esophageal squamous cell carcinoma (ESCC) U.S. FDA accepts Biologics License Application in...
- 435Wire Stories
Drug Farm Doses First Patient in Phase 1 Trial for ALPK1 Inhibitor, DF-003
First-in-human trial for DF-003, the 2nd compound from IDInVivo and MedChem5 platform to enter clinical trials GUILFORD, Conn. & SHANGHAI–(BUSINESS WIRE)–Drug Farm,...
- 469Wire Stories
BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA® (tislelizumab)
Regulatory marketing applications for U.S. and EU under review, with plans to expand TEVIMBRA commercial presence worldwide TEVIMBRA is the cornerstone of...
- 869News
Add a Touch of Kyoto Style to Your Home with the Second Wave of SOU・SOU X Doraemon Collectibles
Introducing the SOU GOOD UV Umbrella with Quick-Dry Pouch, Limited Edition SOU・SOU Doraemon Plushie and SOU GOOD Soft Cushion HONG KONG SAR...
- 502News
Dusit International expands its offerings across the lodging spectrum, introduces two new hotel brands – ‘Dusit Collection’ and ‘Devarana – Dusit Retreats’
New brands set to redefine luxury hospitality with a wave of owner interest. BANGKOK, THAILAND – Media OutReach – 19 September 2023...
